See also this year's filing and all EDGAR filings for this company.
PDF Report 0000931059_2017_Rennova_Health_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 4.679831657095631e-08, 'aggregate_val': 21368289, 'exp_sum': 21368290, 'exp_to_value': {'LongTermLiabilities': 0, 'LiabilitiesCurrent': 19564768, 'remainder_Liabilities': 1803522}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000931059, Rennova Health Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 3,220,639 |
| 3 | PropertyPlantAndEquipment | 3,096,602 |
| 4 | remainder_Assets | 165,152 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 19,564,768 |
| 7 | remainder_Liabilities | 1,803,521 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 1,695,233 |
| 10 | GeneralAndAdministrativeExpense | 23,695,381 |
| 11 | GoodwillImpairmentLoss | 1,038,285 |
| 12 | OperatingCostsAndExpenses | 2,074,463 |
| 13 | DepreciationDepletionAndAmortization | 3,046,902 |
| 14 | SellingAndMarketingExpense | 2,457,050 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 2,895,657 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | 4,289,284 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,482,393 |
| 1 | Liabilities | 21,368,289 |
| 2 | Expenses | 36,902,971 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -14,885,896 |
| 5 | NetIncome | -32,613,687 |
| 6 | ComprehensiveNetIncome | -32,613,687 |
| 7 | BaseVar | 34,521,468 |
| 8 | EconomicCapitalRatio | -5.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
